BUTIROSIN
UNII 8S52KR0L58

Substance Identification & Data

This profile provides standardized clinical and technical data for Butirosin, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8S52KR0L58.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 12772-35-9 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
8S52KR0L58
CAS Registry Number
12772-35-9
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
BUTIROSIN
Official standardized name for this substance within the FDA UNII nomenclature system.
NCI Thesaurus
National Cancer Institute reference terminology for clinical and research data.
INN ID
3020
Sequential identifier assigned via the WHO International Nonproprietary Name program.
Substance Type
mixture
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Butirosin. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

FDA Official Name

BUTIROSIN

Common Names & Synonyms

A MIXTURE OF TWO COMPONENTS, BUTIROSIN A (80-85%) AND BUTIROSIN B (15-20%)
AMBUTYROSIN
AMINOGLYCOSIDIC ANTIBIOTIC COMPLEX OBTAINED FROM FERMENTATION FILTRATES OF MUCOID STRAINS OF BACILLUS CIRCULANS (NRRL B-3312 AND B-3313)
BUTIROSIN [INN]
BUTIROSIN [MI]